Compounded drugs are required to exclusively use ingredients from FDA-licensed facilities, and test sterile compounds for potency, sterility, and purity
Retatrutide, however, distinguishes itself with its "triple G" approach, targeting three receptors that influence appetite and energy expenditure
All other appetite ratings followed similar patterns, however, with no significant effects between treatment or when compared with baseline (Fig
Reported positive in December 2025, first Phase 3 readout of the program
Participants who made it past week 12 without stopping had an 87% chance of hitting at least 15% total weight loss by week 48
How people are using GLP-1s People with type 2 diabetes are using GLP-1 receptor agonists to improve glycemic control, reduce reliance on insulin/other drugs, and reduce risk of diabetes-related complications